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Abstract  
Objective: Blood component transfusion is increasingly promoted in sub-Saharan Africa (SSA), but is 
resource-intensive so whole blood is often used.  We examined SSA recommendations about whole 
blood and packed red cell transfusions for pregnancy-related bleeding or anaemia, and paediatric 
anaemia, and evaluated the evidence underpinning these recommendations.   
Method: Relevant SSA guidelines were identified using five electronic databases, websites for SSA 
Ministries of Health, blood transfusion services and WHO. To facilitate comparisons, indications for 
transfusing packed red cells or whole blood within these guidelines and reasons given for these 
recommendations were recorded on a pre-designed matrix. The AGREE II tool was used to appraise 
guidelines that gave a reason for recommending either packed red cells or whole blood. We 
systematically searched MEDLINE, CINAHL, Global Health, Cochrane library and NHSBT Transfusion 
Evidence Library, using PRISMA guidelines, for clinical studies comparing whole blood with packed 
red cells or combined blood components in obstetric bleeding or anaemia, or paediatric anaemia. 
Characteristics and findings of included studies were extracted in a standardised format and 
narratively summarised.  
Results: 32 English language guidelines from 15 SSA countries mentioned packed red cell or whole 
blood use for our conditions of interest. Only seven guidelines justified their recommendation for 
using packed red cells or whole blood. No recommendations or justifications had supporting 
citations to research evidence. 33 full-text papers, from 11,234 citations, were reviewed but only 
one study met our inclusion criteria. This was a single-centre study in post-partum haemorrhage.  
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Conclusion: Evidence comparing whole blood and packed red cell transfusion for common paediatric 
and maternal indications is virtually absent in SSA. Therefore, it is unclear whether policies 
promoting red cells over whole blood transfusion are clinically appropriate. Building a relevant 
evidence base will help develop effective policies promoting the most appropriate use of blood in 
African settings.  
 
Keywords: Whole blood; packed red cells; Sub-Saharan Africa; systematic review; evidence-based 
medicine; AGREE II; clinical guideline quality; transfusion medicine; paediatric anaemia; obstetric 
haemorrhage; pregnancy-related anaemia 
 
Introduction  
In sub-Saharan Africa (SSA) and other low- and middle-income regions, the majority of blood 
transfusions are given as whole blood.  High-income countries use preparations of red cell 
concentrates for transfusions rather than whole blood, which is in line with international 
recommendations. This involves removing the majority of plasma from donated whole blood by 
centrifugation and adding an additive solution (for example from the United Kingdom see 
https://www.transfusionguidelines.org/transfusion-handbook/3-providing-safe-blood/3-3-blood-
products). Red cell preparations are being increasingly promoted in sub-Saharan Africa, but whether 
the exclusive use of packed red cell transfusions, which for the purposes of this study we define as 
any preparation of red blood cells derived from one unit of whole blood, is necessary or beneficial in 
SSA versus whole blood, is unclear. Understanding why packed red cells are recommended, and the 
evidence to support these recommendations, is important to ensure the most appropriate use of 
packed red cells and whole blood for clinical use in SSA.  
Transfusion services in SSA experience chronic shortages of blood and have traditionally 
been hospital-based models in which relatives and friends donate blood for patients in the hospital. 
They also differ from those in high-income countries in terms of the demands for blood and patterns 
of blood use, and the technical, logistic and financial constraints that they face.  In much of SSA, the 
majority of blood is given as whole blood for emergency transfusions. The most common reasons for 
transfusion are severe paediatric anaemia (1, 2) and obstetric-related anaemia and blood loss (3-5). 
By contrast, whole blood use in high-income settings is uncommon and almost all transfusions are 
packed red cells. The transfusion services are managed through partially or fully centralised 
collection, processing and distribution networks (6-8) and transfusions are generally planned and 
commonly used for chronic conditions in older patients, such as to support chemotherapy (9, 10).  
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The main role of transfusion services is to provide red blood cells for transfusion, whether in 
the form of whole blood or of packed red cell transfusions. The arguments that favour the use of 
packed red cells or whole blood include concerns around the risks of circulatory overload with whole 
blood or the loss of potentially beneficial clotting factors with packed cells. Separation of red cells 
from whole blood means that remaining plasma can be used for transfusion or fractionated into 
blood products.  However, in low and middle-income countries (LMIC) the capacity to use plasma 
directly or as products, is limited and fractionation facilities are very scarce (11).  
Separation of donated whole blood to give red cell concentrates for transfusion is being 
strongly promoted in SSA (12), but the extent to which this recommendation is evidenced by Africa-
relevant clinical research is unclear. Given the differences in blood demands, supply and transfusion 
service organisation in SSA compared to high resource regions, there is a need to clarify the benefit 
of using packed red cells instead of whole blood in SSA. Evaluating the evidence for transfusing 
packed red cells rather than whole blood for common clinical indications in SSA will help to ensure 
clinical guidelines and funding priorities for strengthening African transfusion capacity are based on 
sound evidence. More research in this area was recognised as a priority at a meeting to discuss 
transfusion research priorities in SSA in 2015 (13).   
The purpose of this study was to synthesize recommendations from national transfusion 
guidelines from SSA concerning the use of packed red cells or whole blood and to conduct a 
systematic scoping review to evaluate the available evidence relevant for the African context, 
underpinning these recommendations. The review focused on the use of packed red cells or whole 
blood for the most common indications for transfusion in SSA – namely severe paediatric anaemia, 
pregnancy-related anaemia and obstetric haemorrhage.  
Methods 
Our overall approach to this study was to identify guidelines from SSA covering a range of clinical 
specialities and conditions (i.e. in general medicine, obstetric, paediatric, neonatal, transfusion and 
malaria) that included recommendations regarding the use of packed red cells and whole blood. This 
yielded information about which conditions packed red cells and whole blood transfusions were 
recommended for and why. For guidelines that gave a justification for their recommendations we 
used the AGREEII appraisal tool to assess the quality of the guidelines. We then performed a 
literature search for clinical studies comparing packed red cells with whole blood for obstetric 
haemorrhage, pregnancy-related anaemia and paediatric anaemia, which are the commonest 
indications for transfusion in SSA settings. The evidence obtained from the literature search was 
compared to the justifications for recommendations within the guidelines and an assessment made 
of the extent to which policy recommendations were supported by scientific evidence.  
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Identification and Appraisal of Sub-Saharan African Guidelines Mentioning Whole Blood or Packed 
Red Cell Use  
We searched for SSA guidelines from general medicine, obstetrics, paediatrics, neonatal medicine, 
malaria and transfusion that mentioned whole blood or packed red cell use in order to synthesize 
the recommendations and the evidence used to make the recommendations. Information was 
sought on the following three questions: For what conditions were packed red cells and whole blood 
recommended? What explanations did the guidelines give for using either blood whole blood or 
packed red cells in specific clinical settings? To what extent were these recommendations based on 
an appraisal of the clinical evidence?  
One author (NK) searched for national and regional guidelines from SSA that contained 
recommendations regarding packed red cell and whole blood use in five databases: WHO IRIS, WHO 
AFROLIB, WHO AIM, Google Scholar and Pubmed. NK also performed grey literature searches using 
national Ministry of Health and blood transfusion service websites from SSA countries, and the WHO 
website, using combinations of word searches in Google, for relevant guidelines, including national 
standard treatment guidelines, maternal, neonatal and paediatric guidelines, malaria guidelines and 
clinical transfusion guidelines.  
Inclusion criteria for publications were guidelines that described the use of whole blood or 
packed red cell transfusions rather than simply “blood”, were in English, were available on the 
internet, and were intended for use within SSA. Where multiple editions of the same guideline were 
available, only the most recent one was used. No publication date restriction was applied and there 
was no restriction on age or other characteristics of transfusion recipients.  Besides including 
guidelines that made recommendations regarding packed red cell or whole blood use for specific 
paediatric or obstetric indications, we also included guidelines that made a general preferential 
statement regarding packed red cell or whole blood, use irrespective of indication or patient group, 
if it was deemed to be written in a way that was relevant to paediatric or obstetric practice.  
 
Information from relevant guidelines was recorded onto a pre-piloted data extraction form. 
This included information on the country of origin and scope of the guideline, year of publication, 
indications given within the guideline for transfusing packed red cells or whole blood and reasons 
given in the guideline for using either blood component in these situations. Guidelines differed in 
the level of detail with which they defined specific indications for transfusion.  Therefore attempts to 
generalise these indications for transfusion into simple categories such as “obstetric anaemia” and 
“obstetric haemorrhage” would mask a lot of this detail and reduce the specificity of our 
conclusions. Thus, information on indications for transfusing packed red cells or whole blood within 
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identified guidelines and the reasons given for these recommendations were tabulated into broad 
categories of indications that allowed guidelines to be compared while maintaining as much detail as 
possible.    
For guidelines whose recommendations for whole blood and packed red cell use were based 
on references to scientific literature, or which gave some other justification for using either 
component, three reviewers (SB, SJ and NK) independently assessed the methodological rigour and 
transparency of guideline development using the Appraisal of Guidelines for Research and 
Evaluation II tool (AGREE II). This is a validated tool to appraise the quality of practice guidelines and 
comprises 23 key items embedded within six domains: scope and purpose, stakeholder Involvement, 
rigour of development, clarity of presentation, applicability and editorial independence (14). Each 
item in each guideline was scored from one to seven by each of the appraisers, with seven being the 
highest score. R data analysis software version 3.4.0 was used to calculate the mean and standard 
deviation of scores for each domain. Scaled domain scores were also calculated using a formula 
recommended by AGREEII (14), which is shown below. 
Scaled domain score (%)      =    (Obtained score – minimum possible score) 
(Maximum possible score – minimum possible score) 
 
The scaled score represented the percentage of the total possible score for each domain that was 
achieved by each guideline.  
 
Identification of Evidence Comparing Packed Red Cells or Whole Blood for Clinical Use  
We followed the five-step Joanna Briggs Institute Guidelines for conducting a systematic scoping 
review, to evaluate the evidence comparing packed red cells with whole blood for severe paediatric 
anaemia, obstetric haemorrhage and pregnancy-related anaemia (15). This type of review aims to 
“rapidly map the evidence available for a research area, for instance when the range and type of 
evidence is heterogeneous or complex” (16), or to cover a broad range of concepts.  We selected 
this method in order to be able to cover evidence related to a range of conditions, population groups 
(children of different ages, pregnant and post-partum women) and different geographic regions. 
Evaluating the extent to which packed red cells and whole blood have been compared in the 
research literature required interrogation of a range of study designs, including both retrospective 
and prospective studies. We were interested in the extent to which any clinical outcomes were 
reported in the published literature, including mortality, morbidity related to transfusions or to the 
underlying bleeding condition, and comparisons made regarding the amount of blood transfused.  
We did not publish a study protocol beforehand.  
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We focused on three conditions - severe paediatric anaemia, pregnancy-related anaemia 
and post-partum bleeding - because these groups are the major recipients of blood transfusion in 
Africa. In SSA severe anaemia is often multi-factorial so for each of these three conditions our search 
strategy encompassed haemoglobinopathies, malaria, malnutrition and undifferentiated 
presentations with severe anaemia (1, 2) (Appendix 1).  Combining these different search terms 
allowed a wider range of potentially relevant studies to be captured. This approach has also been 
used in a systematic review evaluating the effect of routine blood transfusion in patients with 
malaria and severe anaemia, which also incorporated haemoglobinopathies into its search strategy 
as these are also an important cause of anaemia in many malaria-affected regions (17). Search 
results were reported according to PRISMA guidelines (18).  
The search strategy was built using word variations of key terms, incorporated into MeSH 
headings and keyword searches. Keywords were also extracted from articles retrieved during the 
search and incorporated into the search strategy. Five online databases were searched: MEDLINE 
(Ebscohost, 1946 to March 2017), CINAHL, Global Health databases, and Cochrane library and NHSBT 
Transfusion Evidence Library (1950 to March 2017) with all searches completed by March 2017. 
Results were imported into an online platform, Rayyan QCRI (19) for duplicate extraction.  
Two independent reviewers screened citations and abstracts from retrieved studies for full-
text review and according to pre-specified inclusion criteria which were studies in English, on human 
subjects, and that compared whole blood with packed red cells, or whole blood with combined 
blood components, for paediatric and pregnancy-related anaemia, or conditions relevant to these 
patient groups, or obstetric haemorrhage. For the purpose of this study, packed red cells were 
defined as any preparation of red blood cells derived from one unit of whole blood. No publication 
date or geographic restrictions were applied. A third reviewer independently resolved discrepancies 
that emerged during selection of publications for full review.  
Studies were excluded if we were unable to obtain the English language full text despite 
extensive efforts including through the British Library repository. Studies of autologous transfusion, 
and studies where blood was not transfused directly from a blood bag into a recipients’ vein (such as 
exchange transfusion, intra-uterine transfusion and cardio-pulmonary bypass), were excluded. One 
author (NK) screened the full texts of short-listed studies for subsequent inclusion, and extracted 
information about study characteristics, key findings and major limitations for the included studies, 
into a pre-designed matrix.  
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Results 
Sub-Saharan African Guidelines on the Use of Whole Blood or Packed Red Cells  
32 English-language guidelines from 15 countries were identified that specifically mentioned packed 
red cell or whole blood use. After excluding earlier editions of the same guideline, there were 14 
national Standard Treatment Guidelines, six malaria guidelines, five clinical transfusion guidelines, 
four paediatric guidelines, two maternal health guidelines and one neonatal health guideline 
included in the final analysis (Figure 1 and Table 1). The publication dates of included guidelines 
ranged from 2004 to 2015.   
Guidelines frequently differed in their recommendations – three guidelines recommended 
packed red cells RC for haemorrhage, one recommended fresh whole blood and five suggested 
either packed red cells or whole blood could be used (Figure 2). One guideline recommended packed 
red cells for obstetric haemorrhage; another recommended whole blood. Seven guidelines 
recommended packed red cells for decompensated anaemia, whereas two suggested that packed 
red cells and whole blood were interchangeable. Three separate guidelines from two countries 
recommended packed red cells for decompensated paediatric anaemia; two guidelines from two 
countries suggested that packed red cells and whole blood were interchangeable (Figure 2).  
Only 7 of the 32 (22%) guidelines stated a rationale for recommending packed red cells or 
whole blood use in specific situations (Table 2) and none of these recommendations were 
referenced. These 7 guidelines were appraised using AGREEII. The highest scaled domain score was 
for scope and purpose (median scaled score 57%), which is concerned with how well the overall aim 
and target population of the guideline are described. Clarity of presentation (median scaled score 
48%), which is related to the clarity of language and layout of the guideline, had the second highest 
score. The lowest scores were for rigour of development (median scaled score 14%), which deals 
with the process used to search for and synthesise evidence and the way recommendations were 
developed and updated, and editorial independence (median scaled score 6%), which assesses how 
guideline developers ensured that competing interests did not influence guideline recommendations 
(Figure 3).  
 
Published Evidence Comparing Packed Red Cells or Whole Blood for Clinical Use  
33 publications identified from the initial literature search underwent full-text review and only one 
met the criteria for inclusion (Figure 4). This was a single centre observational study from the USA 
comparing packed cells with whole blood use in obstetric haemorrhage (20). In this study, case notes 
of 1,540 women who were transfused for obstetric haemorrhage with haemodynamic instability 
from March 2002 to June 2006 were reviewed. 659 (43%) women were transfused whole blood only, 
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593 (39%) were transfused packed red cells only and 288 (19%) were transfused combinations of 
blood components including thawed plasma, cryoprecipitate and platelets. Although the rate of 
complications was low, women given only whole blood had a significantly higher incidence of 
transfusion-associated circulatory overload than those who received packed red cells (7% versus 4%, 
p<0.001). They also had a significantly lower incidence of acute tubular necrosis than women given 
packed red cells alone or those given combinations of blood components (0.3% versus 2% and 4%, 
P<0.001). Women given combinations of blood components had a higher incidence of adult 
respiratory distress syndrome, hypofibrinogenaemia and intensive care unit admission than women 
given either packed red cells or whole blood alone. However, this result may have been confounded 
by this group having more comorbidities leading to greater surgical risk, as well as having more 
obstetric complications such as placenta praevia (20). Potential limitations of the study included 
reporting data from a single centre and lack of blinding of researchers to the study groups. However, 
data were prospectively recorded and the hospital transfusion committee regularly audited 
compliance with pre-specified transfusion criteria.  
 
Discussion 
We found no published clinical evidence comparing packed red cells with whole blood for severe 
paediatric anaemia or pregnancy-related anaemia, and only one retrospective study comparing their 
use in obstetric haemorrhage. There were no published studies from SSA. There is therefore a total 
and critical lack of evidence comparing packed red cells with whole blood for common clinical 
indications for transfusion in SSA and there are no data on which to base recommendations for 
choosing between packed red cells and whole blood for the commonest causes of life-threatening 
severe anaemia.  
This lack of evidence is reflected in inconsistencies and absence of references to published 
literature in clinical guidelines from SSA concerning the use of packed red cells or whole blood. 78% 
of guidelines that mentioned packed red cell or whole blood use did not offer any justification for 
their recommendations. Of those that did, none backed it up with references to published literature.  
Although there was broad, but unsubstantiated, consensus across the guidelines in recommending 
packed red cells for the correction of anaemia, there were discrepancies between guidelines 
recommending whole blood and packed red cell use in, for example, haemorrhage and 
decompensated anaemia.  
There are several reasons why packed red cells may be preferred over whole blood and are 
therefore internationally recommended as the component of choice. Splitting whole blood into 
components increases the utility of each donation since the different constituents can be made 
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available for multiple recipients. Packed cells are less likely than whole blood to cause transfusion-
associated circulatory overload due to the smaller volume of blood needed to increment mean 
haemoglobin concentration. In many high-income countries packed red cells are leucodepleted (21) 
and therefore less likely to be associated with febrile and allergic reactions. Centralised blood 
processing systems required for blood component separation and distribution may make it easier for 
services to develop standardised procedures for screening and manipulating blood to improve 
safety.   
In resource-constrained settings, such as SSA, reasons underlying the choice between 
packed red cells and whole blood are likely to be different from those in developed regions. 
Separation and storage of blood components reduces costs to transfusion services and potentially to 
recipients.  An economic study in Zimbabwe showed that the cost of a unit of packed red cells was 
higher than the cost of a unit of whole blood (22). Where resources are scarce, the additional cost of 
component preparation may contribute to making transfusions unaffordable and unsustainable for 
transfusion services to maintain in the absence of external donor funding. A requirement for 
centralised blood processing may deter family replacement donors or local community donors from 
donating (23) and may jeopardise blood from reaching remote areas where distribution 
infrastructure is weak. Although some countries such as South Africa have implemented selective 
leucodepletion of red cell concentrates, leucodepletion is very uncommon in much of SSA, and 
currently likely to be unaffordable. There is a lack of data comparing the incidence and clinical 
impact of febrile reactions in SSA with non-leucodepleted whole blood and packed red cells. There 
has been recent interest in high-income countries in the use of whole, fresh (i.e. 1-2 days old) blood 
to improve haemostasis since in some studies it has been shown to reduce blood loss, possibly 
through improved platelet function (24). In SSA, where blood shortages are extensive and chronic, 
the turnover of blood stocks is rapid and much of the transfused blood would be considered ‘fresh’ 
(25). Transfusion of whole fresh blood might be a more appropriate blood component in SSA for 
common clinical indications for transfusion such as obstetric haemorrhage, which is often 
complicated by dysfunctional haemostasis.   
An important secondary reason for preferring packed red cells over whole blood is that the 
process of packing red cells allows the separation of plasma which can be frozen for clinical use or 
fractionated to make plasma-derived products. However, fresh frozen plasma is frequently regarded 
as the most inappropriately administered blood component (26, 27) and evidence for its use in many 
settings is lacking (28). In SSA, evidence concerning indications for using fresh frozen plasma, and 
clinical experience of its use, are particularly scarce. Furthermore, almost none of the plasma 
produced in SSA is processed into products since there is currently only one plasma fractionation 
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facility, which is located in South Africa, and much of the separated plasma in SSA is not of suitable 
quality to undergo fractionation (11). There are examples from SSA of plasma wastage when whole 
blood is routinely split into packed cells and plasma, despite low demand for plasma for clinical use 
or fractionation ( 11).  
Our study has various strengths and limitations. It combined a comprehensive review of 
national guidelines with a systematic review of the current evidence available to support 
recommendations regarding the use of whole blood or packed red cells for clinical use in SSA. In 
addition to searching for guidelines specifically related to transfusion, we also searched for relevant 
guidelines by speciality and clinical conditions. However, we were only able to include guidelines 
that were in English and available on the internet, so we may have missed some that were in clinical 
use but not available on-line or not in English. Nevertheless, we identified guidelines developed by 
national bodies and hence likely to have significant influence over clinical practices within their 
countries. When more than one edition of a guideline was identified, we included only the most 
recent edition. Despite this, some of the guidelines included were more than ten years old. 
However, these were considered relevant for inclusion as it is likely that such guidelines continue to 
be used by clinicians. Since only a small number of guidelines gave a justification for their 
recommendations and could be appraised using AGREE II, we make no attempt to generalise 
findings about quality to other guidelines.  
The literature search was conducted using best practice ‘PRISMA’ principles with no date 
limitations. However we only included English-language studies. Transfusion issues cover virtually all 
medical specialities; so, to keep the search focused and manageable, it was necessary to restrict our 
search to patient groups that are the biggest users of transfusion in SSA which are maternal and 
non-surgical paediatric patients. This means that our results should not be extrapolated to other 
clinical situations that commonly require transfusion such as trauma or gastrointestinal bleeding. In 
practice, facilities for packing red cells by centrifugation are not always possible, and transfusion of 
plasma-reduced red cells may be used, which are made by hanging donated whole blood to allow 
only the red cells that have sedimented at the bottom of the blood collection bag to be transfused. 
We recognise that this technique for producing red cells may not be covered by the review search 
terms.” 
 In addition to potentially resulting in sub-optimal patient care, inconsistencies in guidelines 
about when to use packed red cells and whole blood in SSA will inevitably lead to difficulties in 
defining goals for quality improvement, effective audit of appropriate blood use and in allocating 
scarce resources. We suggest that increased focus on formulating clinical transfusion guidelines that 
follow accepted international best practices for guideline development, including transparent 
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management of conflicts of interests, and consideration of available evidence through use of the 
GRADE approach would allow guideline developers to demonstrate consideration of practical issues 
to strengthen their recommendations (29). This would help to define locally relevant standards of 
care. The lack of evidence to support the current promotion of widespread use of packed red cells 
over whole blood in SSA urgently needs to be rectified with carefully designed clinical trials 
conducted in different settings in SSA, and economic and implementation research to investigate 
affordability and scalability. There is an emerging research agenda focusing on developing the 
evidence base around African obstetric and paediatric transfusion practices (30). We suggest that 
comparisons of whole blood with packed red cells should be factored into the design of future 
clinical trials in African transfusion medicine. Dedicated cluster-randomised controlled trials 
comparing packed red cells with whole blood, and integrating an economic evaluation component, 
would provide valuable evidence of cost-effectiveness of providing blood for transfusion in settings 
where transfusion services face sizeable logistic constraints. Simply transferring practices from high 
income settings to SSA which has very different clinical indications for transfusion, resources and 
infrastructure, risks producing detrimental unintended consequences such as plasma wastage (11). 
Routine separation of red cells and plasma by national blood services has resource implications, 
which need to be balanced against the potential benefits and effectiveness. This is particularly 
important in the context of SSA where there are legitimate concerns about reliance on external 
funding and sustainability of transfusion series that are based on wealthy country models (22, 31). 
Without high quality research about the appropriate use of whole blood and packed red cells in SSA, 
it will not be possible to develop evidence-informed policies (32). This will potentially have 
significant negative consequences for the clinical effectiveness of transfusions, and the cost, 
availability, and equity of access to blood transfusions in SSA (33).  
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